Toronto, Ontario--(Newsfile Corp. - June 12, 2021) - InterVivo Solutions (IVS) today announced availability of its first data set as part of the COPE^TM program. The program, launched in March, in collaboration with Mindset Pharma Inc. (CSE: MSET) aims to create the world's first preclinical behavioral and pharmacokinetics benchmark data for...